The Global Extracorporeal Shock Wave Lithotripsy Market Continues To Grow Owing To the Increasing Prevalence of Kidney Stone Cases in the World

Extracorporeal Shock Wave Lithotripsy Market
Extracorporeal Shock Wave Lithotripsy Market

Extracorporeal Shock Wave Lithotripsy Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028.

Market Overview:

Extracorporeal shock wave lithotripsy (ESWL) is a non-invasive medical procedure used to treat kidney stones and other urinary tract stones. It involves the use of shock waves to break down the stones into small fragments, which can then be passed out of the body through urine. ESWL is a safe and effective treatment option for kidney stones that are less than 2 centimeters in diameter. It is generally considered to be less invasive than other treatment options, such as surgery, and has a shorter recovery time.

During the procedure, the patient lies on a special table while a machine generates shock waves that are directed toward the area of the body where the stones are located. The shock waves travel through the body and break the stones into small pieces. The procedure is typically done on an outpatient basis and does not require anesthesia, although pain medication may be given to help manage any discomfort.

Competitive Landscape:

Major players operating in the global Extracorporeal Shock Wave Lithotripsy Market include Richard-Wolf, Cook Medical, MTS Medical, Dornier MedTech, and Olympus.

Key Market Drivers:

The prevalence of kidney stones is increasing worldwide, driven by factors such as unhealthy diets, sedentary lifestyles, and genetic predisposition. This is expected to drive the growth of the global extracorporeal shock wave lithotripsy for market, which is a non-invasive and effective treatment option for kidney stones.

The development of new extracorporeal shock wave lithotripsy (ESWL) devices and technologies is estimated to enhance the growth of the global Extracorporeal Shock Wave Lithotripsy Market.

New devices offer improved precision, efficiency, and safety, leading to better patient outcomes and increased adoption by healthcare providers. For instance, in May 2022, the United States Food and Drug Administration (FDA) gave approval to Dornier MedTech's new Nautilis urology table.

Covid-19 Impact Analysis:

The COVID-19 pandemic has had a mixed impact on the global extracorporeal shock wave lithotripsy for market. The postponement or cancellation of elective procedures has led to a decline in demand for ESWL in some regions. However, the increasing incidence of kidney stones during the pandemic due to factors such as reduced physical activity and changes in the diet has led to an increase in demand for ESWL. In addition, the shift towards outpatient care and non-invasive treatments has created new opportunities for ESWL.

Key Takeaways:

· North America is expected to dominate the growth of the global Extracorporeal Shock Wave Lithotripsy Market, owing to the high prevalence of kidney stones and the availability of advanced healthcare infrastructure in the region. For instance, in January 2022, the United States Food and Drug Administration (FDA) gave approval to Applaud Medical's Acoustic Enhancer technology.

· The Asia-Pacific region is estimated to witness high growth in the global extracorporeal shock wave lithotripsy for market, driven by the increasing incidence of kidney stones and the growing demand for non-invasive treatment options in countries such as China and India. For instance, according to the National Institutes of Health (NIH), around 12% of the Indian population is prone to urinary stones.

Comments

Post a Comment

Popular posts from this blog

Sarcopenia Treatment; Training and Physical Exercise Is Key to Counteract Sarcopenia

Image
Sarcopenia Treatment A primary Sarcopenia Treatment is exercise. Researchers have identified resistance training as the specific form of exercise that is most beneficial to individuals with sarcopenia. At present, resistance exercise, protein supplementation, and vitamin D have been established as the basic treatment of sarcopenia. Recent clinical trials on sarcopenia therapies such as physical exercise, nutraceutical, and pharmaceutical interventions have revealed that exercise is the only effective strategy shown to alleviate sarcopenia. Sarcopenia refers to a loss of muscle mass specifically related to aging. It's normal to lose some muscle mass as people age. Sarcopenia has been defined as an age-related, involuntary loss of skeletal muscle mass and strength. Although aging is the main cause of sarcopenia, some other factors contribute to the loss of muscle mass. Getting little or no physical activity on a regular basis puts people at an increased risk of developing sarcopenia
Read more

Bioresorbable Implants Can Also Help To Prevent Complications And Speed Up The Recovery Process

Image
Bioresorbable Implants Medical implants, either passive for structural support or for diagnosis and therapy with active electronics, are widely used in surgical applications. Although they have shown long-term biocompatibility, their removal imposes physical, biological and economical burdens on patients. To overcome this drawback, implantable devices exhibiting biodegradation in the body have been developed. These implants disappear inside the body after a certain time of use, and can be replaced with natural bone. The resorption of Bioresorbable Implants is driven by hydrolysis of the bonds linking their monomers. The amorphous portions of the polymer degrade first, while the crystalline regions remain intact and provide most of their mechanical strength. The monomers are then broken down into lactic and glycolic acids, which are converted to pyruvate and then processed through the citric acid cycle into water and carbon dioxide. The Bioresorbable Implants Market was valued at US$
Read more

Increasing Developments by Key Players Are Expected To Augment the Growth of the Global Digital Pathology Market

Image
 Digital Pathology Digital Pathology Market , by Product Type (Image Analysis Software, Scanner {Bright Field Scanner, Fluorescence Scanner}, Services {Installation & Integration, Maintenance Services, Consulting Services}), by Therapeutic Area (Oncology, Hematology, Autoimmune Disorder, Dermatology, and Others), by Technology (Immunohistochemistry, ISH & FISH, Immunofluorescence and others) End User (Pharmaceutical & Biotechnology Companies, Diagnostic Labs, Hospital Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030. The global Digital Pathology Market is anticipated to reach an estimated value of US$ 884.4 million in 2023 and is projected to grow at a CAGR of 12.2% from 2023 to 2030. Market Overview: Digital pathology refers to the practice of digitizing glass slides containing tissue samples and analyzing them using digital imaging technology
Read more